Vifor Pharma AG banner
V

Vifor Pharma AG
F:G2AB

Watchlist Manager
Vifor Pharma AG
F:G2AB
Watchlist
Price: 30.6 EUR Market Closed
Market Cap: €9.9B

Intrinsic Value

G2AB price has not been updated for more than 1 month. This may indicate that the stock has been delisted.

The intrinsic value for Vifor Pharma AG (G2AB) under the Base Case is 32.17 EUR. Compared with the current market price of 30.6 EUR, the stock appears Undervalued by 5% .

Intrinsic value calculated using DCF
€32.17

Do our valuations actually work? See backtest results .

G2AB Intrinsic Value
32.17
Undervaluation 5%
Intrinsic Value
Price €30.6
V
Monitor G2AB
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value €25.74
Get notified when the price drops into your buy zone
Intrinsic Value €32.17
Current Price €30.6
Margin of Safety 20% €25.74
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Valuation Context
Ask AI Assistant
What other research platforms think about G2AB?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is G2AB valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Vifor Pharma AG.

Explain Valuation
Alternatives to G2AB

Wall St Price Targets

Capital Returns

Competitive Landscape

What is the Intrinsic Value of one G2AB stock?

The intrinsic value for Vifor Pharma AG (G2AB) under the Base Case is 32.17 EUR.

Is G2AB stock undervalued or overvalued?

Compared with the current market price of 30.6 EUR, the stock appears Undervalued by 5% .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett